Well Told Grants

Grants / Department of Health and Human Services / National Institutes of Health

PAR-22-122: Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)

Closed Closed January 6, 2023 Opportunity PAR-22-122

This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2022.

National Institutes of Health offered grants of up to $3.0 million to state and local governments. Applications closed on January 6, 2023.

From the official notice on Grants.gov, last changed January 6, 2023. Checked November 7, 2026.

About this NIH notice

Projects funded under PAR-22-122 were run by National Center for Advancing Translational Sciences (NCATS, 3 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.

Application due dates, page limits and budget limits are set in the notice. Read PAR-22-122 in the NIH Guide.

Key dates

PostedMarch 1, 2022
DeadlineJanuary 6, 2023
Archived by Grants.govFebruary 5, 2023

Who can apply

This opportunity was open to state and local governments.

Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

More grants for state and local governments.

Is this a realistic fit?

What the grant funds

This Funding Opportunity Announcement (FOA) invites applications for Clinical and Translational Science Awards (CTSA) Program consortium-wide resource centers that will rapidly demonstrate and disseminate to the wider consortium innovative resources (to include capabilities) that have established impact at a local or national level. Applications for CTSA consortium-wide centers are expected to rapidly demonstrate and disseminate resources to advance clinical and translational science efforts. Only applications submitted in response to a Notice of Special Interest (NOSI) published by NCATS will be allowed to apply to this FOA.

Category: Health.

Funded under PAR-22-122 so far

NIH funded 3 projects under PAR-22-122 in fiscal 2023 to 2026, at 2 institutions. The median yearly award was $4.9 million.

Most projects: Vanderbilt University Medical Center (Tennessee), 2, Johns Hopkins University (Maryland), 1.

Recently funded projects
ProjectInstitutionFiscal yearAward
Catalyzing and Harmonizing Operational Innovation for Recruitment (CHOIR) U24Vanderbilt University Medical Center2026$326,759
Johns Hopkins University Trial Innovation Center U24Johns Hopkins University2026$4.9 million
Engaging Cooperative Sites for Trial Acceleration, Trust, Innovation, and Capability (ECSTATIC) U24Vanderbilt University Medical Center2026$4.8 million

From NIH RePORTER, which lists each project once per fiscal year it was funded. Amounts are the yearly award.

Who has won National Center for Advancing Translational Sciences grants before

From fiscal 2021 to 2025, National Center for Advancing Translational Sciences (93.350) awarded $3.1 billion across 867 grant awards, an average of $3.6 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
University of Pittsburgh - of the Commonwealth System of Higher EducationPennsylvania15$95.3 million
Vanderbilt University Medical CenterTennessee10$94.6 million
Duke UniversityNorth Carolina11$88.9 million
University of North Carolina at Chapel HillNorth Carolina16$74.5 million
The Johns Hopkins UniversityMaryland20$70.7 million

Top states: California ($405 million), New York ($351 million), Massachusetts ($239 million), North Carolina ($208 million), Pennsylvania ($200 million).

Applying now

This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is PAR-22-122 still open?

No. It closed on January 6, 2023.

Who can apply for Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)?

National Institutes of Health accepted applications from state and local governments. The notice adds further conditions, so read its eligibility section.

What is the deadline for Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)?

Closed January 6, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

How much funding is available?

Awards of up to $3.0 million each.

Who has been funded under PAR-22-122?

NIH RePORTER lists 3 projects funded under PAR-22-122 in fiscal 2023 to 2026, at 2 institutions. The most were at Vanderbilt University Medical Center, Johns Hopkins University.

Who has won National Center for Advancing Translational Sciences grants before?

The largest recipients over five fiscal years were University of Pittsburgh - of the Commonwealth System of Higher Education, Vanderbilt University Medical Center, Duke University. The program made 867 awards worth $3.1 billion in that time.

Similar open grants